menu search

ACOR / Why Acorda Therapeutics Shares Gaining Today?

Why Acorda Therapeutics Shares Gaining Today?
Acorda Therapeutics Inc (NASDAQ: ACOR) announced that Esteve Pharmaceuticals GmbH launched INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Germany.  INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations (OFF episodes) in. Read More
Posted: Jun 16 2022, 09:40
Author Name: Benzinga
Views: 102282

ACOR News  

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 7, 2022

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2022 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corpo more_horizontal

Why Acorda Therapeutics Shares Gaining Today?

By Benzinga
June 16, 2022

Why Acorda Therapeutics Shares Gaining Today?

Acorda Therapeutics Inc (NASDAQ: ACOR) announced that Esteve Pharmaceuticals GmbH launched INBRIJA 33 mg (levodopa inhalation powder, hard capsule more_horizontal

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 11, 2022

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:02 PM ET Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 PM ET Compa more_horizontal

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 9, 2022

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: